Comments
Loading...

scPharmaceuticals

SCPHNASDAQ
Logo brought to you by Benzinga Data
$5.38
-0.04-0.83%
Last update: 11:03 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$13.00
Consensus Price Target1
$18.33

scPharmaceuticals (NASDAQ:SCPH) Stock, Analyst Ratings, Price Targets, Forecasts

scPharmaceuticals Inc has a consensus price target of $18.33 based on the ratings of 6 analysts. The high is $25 issued by Cowen & Co. on December 1, 2022. The low is $13 issued by SVB Leerink on January 27, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on August 19, 2024, May 15, 2024, and March 14, 2024, respectively. With an average price target of $18 between HC Wainwright & Co., there's an implied 234.26% upside for scPharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Craig-Hallum
Maxim Group
SVB Leerink
Cowen & Co.

1calculated from analyst ratings

Analyst Ratings for scPharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for scPharmaceuticals (SCPH) stock?

A

The latest price target for scPharmaceuticals (NASDAQ:SCPH) was reported by HC Wainwright & Co. on August 19, 2024. The analyst firm set a price target for $18.00 expecting SCPH to rise to within 12 months (a possible 234.26% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for scPharmaceuticals (SCPH)?

A

The latest analyst rating for scPharmaceuticals (NASDAQ:SCPH) was provided by HC Wainwright & Co., and scPharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for scPharmaceuticals (SCPH)?

A

The last upgrade for scPharmaceuticals Inc happened on October 11, 2022 when SVB Leerink raised their price target to $11. SVB Leerink previously had a market perform for scPharmaceuticals Inc.

Q

When was the last downgrade for scPharmaceuticals (SCPH)?

A

There is no last downgrade for scPharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for scPharmaceuticals (SCPH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of scPharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for scPharmaceuticals was filed on August 19, 2024 so you should expect the next rating to be made available sometime around August 19, 2025.

Q

Is the Analyst Rating scPharmaceuticals (SCPH) correct?

A

While ratings are subjective and will change, the latest scPharmaceuticals (SCPH) rating was a reiterated with a price target of $18.00 to $18.00. The current price scPharmaceuticals (SCPH) is trading at is $5.39, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch